Anti KRT19 pAb (ATL-HPA002465 w/enhanced validation)

Catalog No:
ATL-HPA002465-25
$290.00
Application: ICC, IHC 
Clonality: Polyclonal 
Host: Rabbit 
Reactivity: Human 
Protein Description: keratin 19
Gene Name: KRT19
Alternative Gene Name: CK19, K19, K1CS, MGC15366
Isotype: IgG
Interspecies mouse/rat: ENSMUSG00000020911: 79%, ENSRNOG00000003899: 74%
Entrez Gene ID: 3880
Uniprot ID: P08727
Buffer: 40% glycerol and PBS (pH 7.2). 0.02% sodium azide is added as preservative.
Storage Temperature: Store at +4°C for short term storage. Long time storage is recommended at -20°C.

Cognate Antibody/Antigen for Anti KRT19 pAb (ATL-HPA002465 w/enhanced validation)
Antigen PrEST Antigen KRT19 (ATL-APrEST86570)
Documents & Links for Anti KRT19 pAb (ATL-HPA002465 w/enhanced validation)
Datasheet Anti KRT19 pAb (ATL-HPA002465 w/enhanced validation) Datasheet (External Link)
Vendor Page Anti KRT19 pAb (ATL-HPA002465 w/enhanced validation) at Atlas

Documents & Links for Anti KRT19 pAb (ATL-HPA002465 w/enhanced validation)
Datasheet Anti KRT19 pAb (ATL-HPA002465 w/enhanced validation) Datasheet (External Link)
Vendor Page Anti KRT19 pAb (ATL-HPA002465 w/enhanced validation)

Citations for Anti KRT19 pAb (ATL-HPA002465 w/enhanced validation) – 8 Found
Antigen Masking During Fixation and Embedding, Dissected.
J Histochem Cytochem. 2017 Jan;65(1):5-20. doi: 10.1369/0022155416673995. Epub 2016 Oct 23.  PubMed
Attenuation of CD47-SIRPα Signal in Cholangiocarcinoma Potentiates Tumor-Associated Macrophage-Mediated Phagocytosis and Suppresses Intrahepatic Metastasis.
Transl Oncol. 2019 Feb;12(2):217-225. doi: 10.1016/j.tranon.2018.10.007. Epub 2018 Nov 9.  PubMed
Diversity of Epithelial-Mesenchymal Phenotypes in Circulating Tumour Cells from Prostate Cancer Patient-Derived Xenograft Models.
Cancers (Basel). 2021 Jun 1;13(11):2750. doi: 10.3390/cancers13112750.  PubMed
Circulating Tumour Cells Indicate the Presence of Residual Disease Post-Castration in Prostate Cancer Patient-Derived Xenograft Models.
Front Cell Dev Biol. 2022 Apr 13;10:858013. doi: 10.3389/fcell.2022.858013. eCollection 2022.  PubMed
Activation of Vimentin Is Critical to Promote a Metastatic Potential of Cholangiocarcinoma Cells.
Oncol Res. 2018 May 7;26(4):605-616. doi: 10.3727/096504017X15009778205068. Epub 2017 Jul 25.  PubMed
Establishment of Highly Transplantable Cholangiocarcinoma Cell Lines from a Patient-Derived Xenograft Mouse Model.
Cells. 2019 May 23;8(5):496. doi: 10.3390/cells8050496.  PubMed
Chromomycin A3 suppresses cholangiocarcinoma growth by induction of S phase cell cycle arrest and suppression of Sp1‑related anti‑apoptotic proteins.
Int J Mol Med. 2020 Apr;45(4):1005-1016. doi: 10.3892/ijmm.2020.4482. Epub 2020 Jan 29.  PubMed
Human Metastatic Cholangiocarcinoma Patient-Derived Xenografts and Tumoroids for Preclinical Drug Evaluation.
Clin Cancer Res. 2023 Jan 17;29(2):432-445. doi: 10.1158/1078-0432.CCR-22-2551.  PubMed